Cargando…
Real-world evidence of the intrinsic limitations of PCR-based EGFR mutation assay in non-small cell lung cancer
Detection of driver gene mutations is important in advanced NSCLC. The cobas EGFR mutation test is a mutant allele-specific real-time PCR assay with limitation owing to its primer design. Next-generation sequencing-based assay has a higher mutation detection coverage; however, its clinical impact re...
Autores principales: | Shen, Chia-I, Chiang, Chi-Lu, Shiao, Tsu-Hui, Luo, Yung-Hung, Chao, Heng-Sheng, Huang, Hsu-Ching, Chiu, Chao-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363455/ https://www.ncbi.nlm.nih.gov/pubmed/35945330 http://dx.doi.org/10.1038/s41598-022-17394-7 |
Ejemplares similares
-
Comparison of the outcome between immunotherapy alone or in combination with chemotherapy in EGFR-mutant non-small cell lung cancer
por: Shen, Chia-I, et al.
Publicado: (2021) -
Dynamic Assessment of Tissue and Plasma EGFR-Activating and T790M Mutations with Droplet Digital PCR Assays for Monitoring Response and Resistance in Non-Small Cell Lung Cancers Treated with EGFR-TKIs
por: Ho, Hsiang-Ling, et al.
Publicado: (2022) -
Old age and
EGFR
mutation status in inoperable early‐stage non‐small cell lung cancer patients receiving stereotactic ablative radiotherapy: A single institute experience of 71 patients in Taiwan
por: Wu, Yuan‐Hung, et al.
Publicado: (2023) -
DOACs – advances and limitations in real world
por: Lee, Lai Heng
Publicado: (2016) -
Evaluation of digital real-time PCR assay as a molecular diagnostic tool for single-cell analysis
por: Chang, Chia-Hao, et al.
Publicado: (2018)